Orphan Disease Drug Costs In The United States- Assessment Of Launch Pricing Trends In Non-Cancer Orphan Diseases And The Future Implications On Health System Access
May 1, 2013, 00:00 AM
10.1016/j.jval.2013.03.014
https://www.valueinhealthjournal.com/article/S1098-3015(13)00085-5/fulltext
Section Title :
Health Care Studies-Expenditure Or Reimbursement Studies
Section Order :
564
First Page :
A2
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(13)00085-5&doi=10.1016/j.jval.2013.03.014